FDA approves first gene therapy for rare immune disorder
The US Food and Drug Administration on March 27 approved the first gene therapy for severe Leukocyte Adhesion Deficiency Type 1 (LAD-1), a rare immune disorder, Medscape reported. The approval marks a significant milestone in gene therapy for primary immunodeficiencies.
The European Medicines Agency on the same day recommended against the use of…
Read More...
European Commission confirms cyberattack on cloud…
The European Union's top executive body confirmed on Friday that it had been hit by a cyberattack. "We have taken immediate steps and contained the attack,"…
Read More...
Afghan minister in Delhi pushes trade boost with India
Afghanistan’s Taliban administration has stepped up its outreach to India with acting Industry and Commerce Minister Alhaj Nooruddin Azizi pitching Kabul as…
Read More...